| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Mar 3, 2025 | Kymera Therapeutics, Inc. | Chief Legal Officer | Sell | 95.0 | +25,259 | 46.07% | ✗ | $68.2K |
| Jan 6, 2025 | Jan 6, 2025 | Kymera Therapeutics, Inc. | Chief Legal Officer | Sell | 42.5 | -3,129 | -5.40% | ✗ | $130.6K |
| Jan 4, 2024 | Jan 5, 2024 | Kymera Therapeutics, Inc. | Chief Legal Officer | Sell | 42.5 | -3,295 | -8.79% | ✗ | $74.4K |